patient care perspectives

Use of 14-3-3η Protein, Multi-Biomarker Disease Activity, and Other Emerging Tests to Profile Patients With Rheumatoid Arthritis

by Jonathan Kay, MD

In certain clinical scenarios, new diagnostic tests such as 14-3-3η protein and multi-biomarker disease activity (MBDA) have been shown to offer ad......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles